Tony is a former managing editor of BRW, Shares, Personal Investor, Asset and CFO magazines. He writes a weekly column for BRW and The Australian Financial Review, specialising in small listed companies,IPOs, entrepreneurship and innovation.
Published 01 March 2012 05:09, Updated 01 March 2012 05:16
By targeting obesity and diabetes, GI Dynamics’ new product could have huge potential.
Comments